Dr Beverly Tsai-Goodman is a consultant in paediatric and foetal cardiology and joined Royal Brompton Hospital in 2017.
She completed her medical studies at the University of Southampton and was awarded a doctorate from the University of Bristol in 2004, where she trained in paediatric cardiology and practised as a consultant until 2016. In addition, she was the leading cardiologist for the Barth Syndrome Specialist Services in Bristol from 2004 to 2014.
She spent 15 months at Boston Children’s Hospital and Harvard Medical School as a senior clinical fellow and trained in cardiac MRI, echocardiography and foetal cardiology during this time.
She recently completed a Masters (MSc) degree in Genomic Medicine at Imperial College London and aims to combine her expertise in paediatric and foetal cardiology with the latest in human genomics.
Dr Beverly Tsai-Goodman is an expert in foetal, new-born, infant and child heart conditions.
Her areas of expertise include:
She is a member of the foetal cardiac subcommittee for the NHS Foetal Anomaly Screening Programme (FSAP). This group develops national guidelines on foetal cardiac screening. Also, she helped develop the cardiac section of the consensus statement for patients with 22q11, supported by the MAX appeal.
Dr Tsai-Goodman has had a leading role in a several research projects and in many peer-reviewed journals. This includes using MRI as a tool in assessing foetal circulation to developing a non-invasive tool to track new born cardiac output.
Dr Tsai-Goodman has completed a postgraduate certificate in medical education (PG Cert Med Ed) and convenes the ‘Echocardiography for Neonatologists’ course each year. This 2-day practical course attracts delegates from many countries, including Australia, Canada, Europe, South Africa and the USA.
She has delivered the course in St Kitts and aims to extend it to Pakistan, as well as the Middle East. In addition, she has delivered lectures, practical training and live scans at local and national levels.